Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Positive symbols : GLAXF save search
Zentalis to present positive clinical data in ovarian cancer combining azenosertib and chemotherapy, including at the 2023 ASCO Annual Meeting
Published: 2023-04-26 (Crawled : 15:00) - biospace.com/
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -4.57%
H: 0.22%
C: -1.98%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.03%
H: 0.3%
C: -2.63%
ZNTL | $12.97 3.43% 3.32% 1M
|
Health Technology
|
| O: -0.23%
H: 0.18%
C: -1.43%
asco positive cancer meeting
Zentalis to present positive clinical data in ovarian cancer combining azenosertib and chemotherapy, including clinical support for Cyclin E1 expression as predictive marker for clinical benefit from azenosertib at the 2023 ASCO Annual Meeting
Published: 2023-04-26 (Crawled : 14:20) - globenewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -4.57%
H: 0.22%
C: -1.98%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.03%
H: 0.3%
C: -2.63%
ZNTL | $12.97 3.43% 3.32% 1M
|
Health Technology
|
| O: -0.23%
H: 0.18%
C: -1.43%
asco positive cancer meeting
CureVac veröffentlicht positive Daten bei älteren Erwachsenen aus COVID-19- und Grippe-mRNA-Impfstoffentwicklungsprogrammen
Published: 2023-01-30 (Crawled : 12:20) - curevac.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -2.59%
H: 3.12%
C: 1.79%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.74%
H: 0.2%
C: -1.24%
CVAC | $2.44 0.0% 790K
|
Health Technology
|
| O: 5.36%
H: 4.0%
C: -3.5%
covid-19 positive
CureVac gibt positive Daten aus gemeinsamen COVID-19- und Grippe-mRNA-Impfstoffentwicklungsprogrammen bekannt
Published: 2023-01-06 (Crawled : 12:20) - curevac.com
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.44%
H: 1.85%
C: 1.72%
CVAC | $2.44 0.0% 790K
|
Health Technology
|
| O: 12.7%
H: 15.44%
C: 14.88%
covid-19 positive
Global Nutraceuticals Market Report 2022-2027: Growing Demand for Personalized Nutrition to have Positive Impact
Published: 2022-10-25 (Crawled : 16:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 5.27%
H: 0.0%
C: -2.17%
HLF | $8.84 2.91% 0.0% 1.5M
|
Distribution Services
|
| O: 0.24%
H: 6.9%
C: 6.42%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.57%
H: 1.16%
C: 0.94%
GIS 4 | $70.42 1.93% -0.1% 4M
|
Consumer Non-Durables
|
| O: -0.26%
H: 1.46%
C: 1.14%
ADM | News | $62.6 1.43% 0.0% 7.9M
|
Process Industries
|
| O: 1.06%
H: 1.58%
C: 1.01%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.22%
H: 0.85%
C: -0.12%
global nutrition report growing impact positive market
ViiV Healthcare presents positive proof-of-concept findings for N6LS, an investigational, broadly neutralising antibody (bNAb) offering a potential new approach for the treatment of HIV
Published: 2022-10-25 (Crawled : 15:20) - biospace.com/
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 5.27%
H: 0.0%
C: -2.17%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.59%
H: 1.21%
C: 0.71%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.57%
H: 1.16%
C: 0.94%
offering treatment antibody hiv potential positive
Zai Lab Presents Positive Results from Phase 3 PRIME Study of ZEJULA® (Niraparib) at Society of Gynecologic Oncology Meeting
Published: 2022-03-21 (Crawled : 01:00) - globenewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 4.8%
H: 4.09%
C: 4.09%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.96%
H: 0.0%
C: 0.0%
ZLAB | $14.08 -0.99% -0.99% 470K
|
Health Technology
|
| O: 10.34%
H: 0.0%
C: 0.0%
zejula pos positive results positive results phase 3 primec
GSK announces positive Phase III efficacy and safety data for daprodustat in patients with anaemia due to chronic kidney disease
Published: 2021-11-05 (Crawled : 22:00) - biospace.com/
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 3.11%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
disease positive kidney
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
KUKE | $2.88 2.49% 7.64% 360K
|
CXM 4 | $11.34 -0.44% 4.27% 1.7M
|
Information
RNR 4 | $224.74 0.85% 3.52% 310K
|
Finance
BSBR | $5.25 2.54% 0.38% 430K
|
Finance
JOE 4 | $54.88 1.22% 0.22% 210K
|
Finance
MUSA 4 | $417.23 1.06% 0.01% 170K
|
Retail Trade
JBI 4 | $15.14 1.34% 0.0% 2.9M
|
SBS | $15.49 -1.59% -0.84% 4.6M
|
Utilities
ARCO | $10.9 1.3% -3.39% 1.1M
|
Consumer Services
NOV 4 | $18.75 1.35% -6.67% 3.2M
|
Industrial Services
Your saved searches
Save your searches and get alerts when important news are released.